Picton Mahoney Asset Management bought a new stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 75,000 shares of the company's stock, valued at approximately $767,000. Picton Mahoney Asset Management owned about 0.33% of Oaktree Acquisition Corp. III Life Sciences as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. K2 Principal Fund L.P. acquired a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at approximately $1,945,000. Sculptor Capital LP acquired a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at approximately $2,490,000. Lighthouse Investment Partners LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at approximately $3,039,000. TENOR CAPITAL MANAGEMENT Co. L.P. bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at approximately $2,988,000. Finally, Two Sigma Investments LP bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at approximately $4,358,000.
Oaktree Acquisition Corp. III Life Sciences Stock Performance
Shares of NASDAQ:OACC remained flat at $10.47 during trading on Friday. 1,811 shares of the stock were exchanged, compared to its average volume of 18,544. Oaktree Acquisition Corp. III Life Sciences has a 12 month low of $9.95 and a 12 month high of $10.85. The business has a 50 day simple moving average of $10.48.
Oaktree Acquisition Corp. III Life Sciences Company Profile
(
Free Report)
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.
Further Reading
Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.
While Oaktree Acquisition Corp. III Life Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
